US Stocks Mixed; Perion Network Shares Plunge
U.S. stocks traded mixed this morning, with the Nasdaq Composite falling around 50 points on Monday. Following the…
Tonix Pharmaceuticals Presents Two Oral Presentations And One Poster Presentation Involving TNX-1500 At The American Transplant Congress 2024
TNX-1500 displays potential as a monotherapy or combination therapy to prevent rejection in organ transplantation in allograft and xenograft animal models Research Directed by Faculty of the Center for
Tonix Pharmaceuticals To Present New Data On Tonmya Suggesting Activity For Improvement In Fibromyalgia-Associated Depression Severity In An Oral Presentation At ASCP Annual Meeting
Tonmya treatment was associated with improvement in depressive symptoms as measured by the Beck Depression Inventory-II In addition, post-hoc analyses showed improvement in depression, anxiety, memory and energy
Tonix Pharmaceuticals Reports Key Findings From Initial Phase Of EVERSANA Market Opportunity Analysis For Tonmya For The Management Of Fibromyalgia
Tonmya is a potential new first-line, centrally acting non-opioid analgesic for the management of fibromyalgia, supported by statistically significant results from two Phase 3 trials Primary physician research found
Tonix Pharmaceuticals Stock (TNXP) Hits A New All-Time Low: What’s Going On?
Tonix Pharmaceuticals shares are trading lower by 7.2% Monday. The company last week announced the pricing of a $4.4 million registered direct offering.
12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers Avalo Therapeutics (NASDAQ:AVTX) shares increased by 364.8% to $22.08 during Friday’s regular session. The market value of…
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss.
Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.
Why Tonix Pharmaceuticals Stock (TNXP) Is Getting Obliterated
Tonix Pharmaceuticals shares are trading lower by 22.3% Thursday afternoon. The company announced the pricing of a $4.4 million registered direct offering.
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Avalo Therapeutics (NASDAQ:AVTX) stock rose 363.1% to $22.0 during Thursday’s regular session. The company’s market cap stands…
Tonix Pharmaceuticals Hosted KOL Webinar On Phase 3 Fibromyalgia Trial For Tonmya, Plans To File NDA For FDA Approval In Second Half Of 2024
Clinical results show that Tonyma™ has broad-spectrum activity, addressing the three core fibromyalgia symptoms: pain, fatigue, and sleep disturbance Tonmya™ has a favorable tolerability profile